Pharmaceuticals (Basel)
From Bioblast
| Journal title and website | Pharmaceuticals |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Qvit 2022 Pharmaceuticals (Basel) | Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Mochly-Rosen D (2022) A selective inhibitor of cardiac troponin I phosphorylation by delta protein kinase C (ฮดPKC) as a treatment for ischemia-reperfusion injury. Pharmaceuticals (Basel) 15:271. https://doi.org/10.3390/ph15030271 | 2022 | PMID: 35337069 Open Access |
| Schiller 2022 Pharmaceuticals (Basel) | Schiller J, Zickermann V (2022) Binding of natural inhibitors to respiratory complex I. https://doi.org/10.3390/ph15091088 | 2022 | Pharmaceuticals (Basel) 15:1088. PMID: 36145309 Open Access |
| Viel 2021 Pharmaceuticals (Basel) | Viel C, Brandtner AT, Weiรhaar A, Lehto A, Fuchs M, Klein J (2021) Effects of magnesium orotate, benfotiamine and a combination of vitamins on mitochondrial and cholinergic function in the TgF344-AD rat model of Alzheimer's disease. https://doi.org/10.3390/ph14121218 | 2021 | Pharmaceuticals (Basel) 14:1218. PMID: 34959619 Open Access |
| Litwiniuk 2021 Pharmaceuticals (Basel) | Litwiniuk A, Baranowska-Bik A, Domaลska A, Kalisz M, Bik W (2021) Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases. Pharmaceuticals (Basel) 14:1221. https://doi.org/10.3390/ph14121221 | 2021 | PMID: 34959622 Open Access |
| Robledo-Cadena 2020 Pharmaceuticals (Basel) | Robledo-Cadena DX, Gallardo-Pรฉrez JC, Dรกvila-Borja V, Pacheco-Velรกzquez SC, Belmont-Dรญaz JA, Ralph SJ, Blanco-Carpintero BA, Moreno-Sรกnchez R, Rodrรญguez-Enrรญquez S (2020) Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells. Pharmaceuticals (Basel) 13:463. | 2020 | PMID: 33333716 Open Access |
